Transfusion Diagnostic Testing Market

Transfusion diagnostics testing is the process of testing and matching of blood and blood products which are to be transfused to patients. The various complications associated with blood transfusion process are adverse reactions at the time of blood transfusion or few days or months later. Some of the common wrongful blood transfusion reactions include fever, skin rashes, nausea and back pain. Transfusion diagnostic testing is an essential part of healthcare process and provides critical information to physicians and patients. It helps in diagnosis of diseases and assessing the risk associated with transfusion to particular disease in patient and thus determining appropriate therapy or treatment to be administered to the patient.

Transfusion diagnostic testing market is segmented based on following:

• Technology
  • Immunoassay
  • Nucleic acid testing
• Instrumentation
  • Automated blood grouping and typing system
  • Immunoassay system
  • Nucleic acid testing system
• End-users
  • Central hospital laboratories
  • Private laboratories
  • Free standing blood donor laboratories/plasma testing laboratories
  • Hospital blood banks

Globally, North America dominates the transfusion diagnostics testing market and is followed by Europe. Developing countries of Asia such as Japan, China and India along with regions including Latin America and Middle–East Asia represent the emerging markets for transfusion diagnostics testing. The market growth in developed nations has been attributed to the growth in aging population as well as increased prevalence of diseases such as leukemia, lymphoma, myeloma, kidney failures and several hereditary disorders which need periodic blood transfusion.

Some of the major factors driving the transfusion diagnostics testing market include ongoing technological advances, new product introductions, increase in aging population, rise in prevalence of blood disorders requiring blood transfusion treatment, improved reimbursement policies and encouragement to blood donation programs by blood collection agencies.

Some of the leading manufacturers in transfusion diagnostic testing market include Abbott Laboratories, BioMerieux SA, Bio-Rad Laboratories, Inc., Chiron Corporation, DiaMed, Inc., Fujirebio Diagnostics, Inc., Immucor, Inc., Ortho-Clinical Diagnostics, Inc. and Roche Diagnostics Corporation.

The process of matching and testing of blood and blood products to be transfused to patients is known as transfusion diagnostics testing. The various complications associated with the blood transfusion process include adverse reactions that occur during the transfusion or a few days or months later. Fever, nausea, back pain, and skin rashes are some of the most common wrongful blood transfusion reactions. Transfusion diagnostic testing is an important part of the healthcare process because it provides important information to both patients and physicians. It aids in disease diagnosis and assessing the risk of transfusion to a specific disease in a patient, allowing appropriate therapy or treatment to be administered to the patient. The advent of latest technologies in medical science and the increasing awareness about the possibility of treating complex diseases that includes blood transfusion procedures are likely to increase the sales projections of the global transfusion diagnostic testing market.

North America emerged as the largest revenue generator for the transfusion diagnostics testing market, with Europe in second position. Dominance of North American market is attributed to the rise in ageing population, and the growing prevalence of various diseases such as kidney failures, myeloma, lymphoma, leukemia, and other hereditary disorders that constitutes blood transfusions at periodic levels. The emerging markets for transfusion diagnostics testing include developing Asian countries such as India, Japan, and China as well as other regions such as Latin America and the Middle East Asia.

The nature of competition for the global transfusion diagnostic testing market is fragmented owing to the presence of multiple players. Companies are also getting government support in terms of blood donation programs, reimbursement policies, and awareness programs about blood transfusion and its importance to gain impetus in the overall market competition. Besides this, the rising number of reimbursement policies and increasing promotion to donate blood for social causes will further help in creating new revenue generation opportunities for the global transfusion diagnostic testing market in the coming years.